dc.contributor.author | KONUKOĞLU, Dildar | |
dc.contributor.author | TABAK, Ömer Fehmi | |
dc.contributor.author | GEMİCİOĞLU, Bilun | |
dc.contributor.author | ERGİNÖZ, Ethem | |
dc.contributor.author | ERDOĞAN, Mehmet Sarper | |
dc.contributor.author | ACAR, Hazal Cansu | |
dc.contributor.author | CAN, Gunay | |
dc.contributor.author | KARAALİ, Rıdvan | |
dc.contributor.author | BÖREKÇİ, Şermin | |
dc.contributor.author | BALKAN, İlker İnanç | |
dc.date.accessioned | 2021-03-07T01:01:03Z | |
dc.date.available | 2021-03-07T01:01:03Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | ACAR H. C. , CAN G., KARAALİ R., BÖREKÇİ Ş., BALKAN İ. İ. , GEMİCİOĞLU B., KONUKOĞLU D., ERGİNÖZ E., ERDOĞAN M. S. , TABAK Ö. F. , "An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital", BMC INFECTIOUS DISEASES, cilt.21, sa.1, 2021 | |
dc.identifier.issn | 1471-2334 | |
dc.identifier.other | av_61933a35-5442-46ab-b385-d36ee8bcc9e9 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/167402 | |
dc.identifier.uri | https://doi.org/10.1186/s12879-021-05845-x | |
dc.description.abstract | BackgroundOne-fifth of COVID-19 patients are seriously and critically ill cases and have a worse prognosis than non-severe cases. Although there is no specific treatment available for COVID-19, early recognition and supportive treatment may reduce the mortality. The aim of this study is to develop a functional nomogram that can be used by clinicians to estimate the risk of in-hospital mortality in patients hospitalized and treated for COVID-19 disease, and to compare the accuracy of model predictions with previous nomograms.MethodsThis retrospective study enrolled 709 patients who were over 18years old and received inpatient treatment for COVID-19 disease. Multivariable Logistic Regression analysis was performed to assess the possible predictors of a fatal outcome. A nomogram was developed with the possible predictors and total point were calculated.ResultsOf the 709 patients treated for COVID-19, 75 (11%) died and 634 survived. The elder age, certain comorbidities (cancer, heart failure, chronic renal failure), dyspnea, lower levels of oxygen saturation and hematocrit, higher levels of C-reactive protein, aspartate aminotransferase and ferritin were independent risk factors for mortality. The prediction ability of total points was excellent (Area Under Curve=0.922).ConclusionsThe nomogram developed in this study can be used by clinicians as a practical and effective tool in mortality risk estimation. So that with early diagnosis and intervention mortality in COVID-19 patients may be reduced. | |
dc.language.iso | eng | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Immunology | |
dc.subject | Infectious Diseases | |
dc.subject | General Immunology and Microbiology | |
dc.subject | Temel Bilimler | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | İmmünoloji | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.title | An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital | |
dc.type | Makale | |
dc.relation.journal | BMC INFECTIOUS DISEASES | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 21 | |
dc.identifier.issue | 1 | |
dc.contributor.firstauthorID | 2528026 | |